Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjian Min

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|December 29, 2022
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune MicroenvironmentChengliang Sun, Mingxiao Yin, Yao Cheng, et al.
Theranostics|October 24, 2022
A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cellsCanzhen Liu, Xiaoxu Wang, Xiaonan Wang, et al.
European Heart Journal|May 18, 2026
Cardiac α4β2 nicotinic receptors as a therapeutic target for fatal ventricular arrhythmiasDuanyang Xie, Wenjian Min, Guanghua Wang, et al.
Nature Cancer|February 10, 2025
Targeting ADAR1 with a small molecule for the treatment of prostate cancerXiao Wang, Jiaxing Li, Yasheng Zhu, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|December 29, 2022
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune MicroenvironmentChengliang Sun, Mingxiao Yin, Yao Cheng, et al.
Theranostics|October 24, 2022
A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cellsCanzhen Liu, Xiaoxu Wang, Xiaonan Wang, et al.
European Heart Journal|May 18, 2026
Cardiac α4β2 nicotinic receptors as a therapeutic target for fatal ventricular arrhythmiasDuanyang Xie, Wenjian Min, Guanghua Wang, et al.
Nature Cancer|February 10, 2025
Targeting ADAR1 with a small molecule for the treatment of prostate cancerXiao Wang, Jiaxing Li, Yasheng Zhu, et al.
Pageof 5